| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 4.74B | 6.56B | 6.01B | 3.91B | 3.86B |
| Gross Profit | 4.34B | 4.20B | 3.94B | 3.29B | 3.18B |
| EBITDA | 2.26B | 1.66B | 1.93B | -386.55M | 503.95M |
| Net Income | 3.04B | 1.95B | 2.05B | -178.36M | 309.51M |
Balance Sheet | |||||
| Total Assets | 129.34B | 122.60B | 122.61B | 120.24B | 137.87B |
| Cash, Cash Equivalents and Short-Term Investments | 15.02B | 14.40B | 15.58B | 13.60B | 23.05B |
| Total Debt | 11.47B | 12.53B | 12.94B | 10.30B | 12.74B |
| Total Liabilities | 116.11B | 110.95B | 112.63B | 112.37B | 131.69B |
| Stockholders Equity | 13.22B | 11.65B | 9.98B | 7.86B | 6.17B |
Cash Flow | |||||
| Free Cash Flow | 1.62B | -860.42M | 1.66B | 8.32B | -662.86M |
| Operating Cash Flow | 1.74B | -792.00M | 1.77B | 8.38B | -551.54M |
| Investing Cash Flow | 824.66M | 39.15M | 7.08M | 44.09M | -69.07M |
| Financing Cash Flow | -1.18B | -315.03M | -2.73M | 2.37B | 42.93M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | €99.36B | 6.83 | 14.41% | 6.08% | -8.72% | 8.09% | |
74 Outperform | €24.27B | 10.55 | 13.48% | 6.09% | 10.56% | 10.67% | |
73 Outperform | €5.12B | 8.88 | 13.87% | 6.23% | -10.60% | -22.83% | |
68 Neutral | €26.19B | 9.68 | 19.13% | 9.69% | 10.29% | -0.75% | |
66 Neutral | €19.95B | 5.75 | 18.92% | 8.25% | -10.25% | 8.52% | |
65 Neutral | €108.98B | 7.03 | 16.86% | 4.15% | 1.30% | 18.00% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |